Phase II Study of Irinotecan (CPT 11) and Cisplatin (CDDP) in Metastatic or Locally Advanced Penile Carcinoma
Phase of Trial: Phase II
Latest Information Update: 16 Jun 2016
At a glance
- Drugs Irinotecan (Primary) ; Cisplatin
- Indications Penile cancer
- Focus Therapeutic Use
- 23 Jul 2009 United Kingdom Clinical Research Network reports accrual to date as 132%; this was identified via CA tool on 15 Jul 2009.
- 15 Jul 2009 New source identified and integrated (United Kingdom Clinical Research Network, 1004)
- 06 Feb 2009 Additional location (Netherland) added as reported by ClinicalTrials.gov.